Treatment of rheumatoid arthritis with mammal beta defensins

Details for Australian Patent Application No. 2009272683 (hide)

Owner Novozymes Adenium Biotech A/S

Inventors Kruse, Thomas; Brinch, Karoline Sidelmann; Kjaerulff, Soeren; Mygind, Per Holse; Andersen, Birgitte; Kjaer, Tanja Maria Rosenkilde

Agent Shelston IP

Pub. Number AU-A-2009272683

PCT Pub. Number WO2010/007168

Priority 09160448.8 15.05.09 EP; 08160761.6 18.07.08 EP

Filing date 17 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/007168 Priority application(s): WO2010/007168

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272719-Pyridazine derivatives as Smo inhibitors

2009272681-Treatment of inflammatory bowel diseases with mammal beta defensins